Showing: 21 - 29 of 29 RESULTS

Global Precision Medicine Market 2020-2030: Focus on Ecosystem, Technology, Application, and Competitive Landscape

The “Global Precision Medicine Market: Focus on Ecosystem, Technology, Application, Country Data (21 Countries), and Competitive Landscape – Analysis and Forecast, 2020-2030” report has been added to ResearchAndMarkets.com’s offering.

Global Precision Medicine Market to Reach $278.61 Billion by 2030

Precision medicine refers to the medicine developed as per an individual’s genetic profile. It provides guidance regarding the prevention, diagnosis, and treatment of diseases. The segmentation of the population is done depending on the genome structure of the individuals and their compatibility with a specific drug molecule.

In the precision medicine market, the application of molecular biology is to study the cause of a patient’s disease at the molecular level, so that target-based therapies or individualized therapies can be applied to cure the patient’s health-related problems.

This industry is gaining traction due to the increasing awareness about healthcare among individuals, integration of smart devices such as smartphones and tablets into healthcare, and increasing collaborations and agreements of IT firms with the diagnostics and biopharmaceutical companies for the development of precision diagnostic tools.

Within the research report, the market is segmented on the basis of product type, ecosystem application, and region, which highlight value propositions and business models useful for industry leaders and stakeholders. The research also comprises country-level analysis, go-to-market strategies of leading players, future opportunities, among others, to detail the scope and provide 360-degree coverage of the domain.

Key Topics Covered:

1 Product Definition

2 Research Scope

3 Research Methodology

4 Global Precision Medicine Market Overview

4.1 Market Definition

4.2 Precision Medicine: A Frontier in the Genesis of Patient-centric Medicine

4.3 Precision Medicine: Remodeling the One-Size-Fits-All Theory to Individually Tailored Therapy

4.4 Initiatives and Programs

4.5 Precision Medicine: Enabling Technologies and Applications

4.5.1 Innovators

4.5.1.1 3D DNA Printing

4.5.1.1.1 Introduction

4.5.1.1.2 Role of 3D DNA Printing

4.5.1.2 RNA-Seq

4.5.1.2.1 Introduction

4.5.1.2.2 Role of RNA-Seq in Precision Medicine

4.5.1.2.3 Key Players

4.5.1.3 4D Molecular Imaging

4.5.1.3.1 Introduction

4.5.1.3.2 Role of 4D Molecular Imaging in Precision Medicine

4.5.1.3.3 Key Players

4.5.2 Early Adopters

4.5.2.1 CRISPR

4.5.2.1.1 Introduction

4.5.2.1.2 Role of CRISPR in Precision Medicine

4.5.2.1.3 Key Players

4.5.2.2 Blockchain

4.5.2.3 Imaging Informatics

4.5.3 Early Majority

4.5.3.1 Artificial Intelligence (AI)

4.5.3.2 Circulating Free DNA (cfDNA)

4.5.3.3 Big Data

4.5.3.4 Next-Generation Sequencing (NGS)

4.5.3.5 Health Informatics

4.5.3.6 Bioinformatics

4.5.4 Late Majority

4.5.4.1 Polymerase Chain Reactions (PCR)

4.5.4.2 Microarray

4.6 COVID-19 Impact on the Global Precision Medicine Market

5 Market Dynamics

5.1 Overview

5.2 Market Drivers

5.2.1 Advancement of Sequencing Technologies

5.2.2 Rising Prevalence of Chronic Diseases

5.2.3 Growing Demand for Preventive Care

5.2.4 Shifting the Significance in Medicine, from Reaction to Prevention

5.2.5 Reducing Adverse Drug Reactions Through Pharmacogenomics Test

5.2.6 Potential to Reduce the Overall Healthcare Cost Across the Globe

5.3 Market Restraints

5.3.1 Unified Framework for Data Integration

5.3.2 Limited Knowledge about Molecular Mechanism/ Interaction

5.3.3 Lack of Robust Reimbursement Landscape

5.3.4 Regulatory Hurdles

5.4 Market Opportunities

5.4.1 Targeted Gene Therapy

5.4.2 Expansion into the Emerging Markets

5.4.3 Collaboration and Partnerships Across Value Chain to Accelerate the Market Entry

6 Industry Insights

Same-Day Delivery Market in US – Actionable Research on COVID-19 | Growing B2C E-commerce to Boost Market Growth

The global same-day delivery market size is poised to grow by USD 9.73 billion during 2020-2024, progressing at a CAGR of about 22% throughout the forecast period, according to the latest report by Technavio. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. Download a Free Sample of REPORT with COVID-19 Crisis and Recovery Analysis.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201001005740/en/

Technavio has announced its latest market research report titled Same-Day Delivery Market in US 2020-2024 (Graphic: Business Wire)

The rising penetration of internet and the growing inclination towards online shopping has significantly contributed to the growth of the B2C e-commerce market in the US. This has increased the demand for parcel delivery services to the B2C e-commerce market. In addition, the growing competition has compelled many e-tailers to reduce their lead time to gain an edge over their rivals in the market. For instance, in 2018, Jet.com introduced same-day delivery for groceries, everyday essentials, and select merchandise in New York. Similarly, in February 2018, Deliv launched Deliv Rx to extend its same-day services to patients, doctors, pharmacies, hospitals, labs, and clinics. All these factors are contributing to the growth of the same-day delivery market in US.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Report Highlights:

  • The major same-day delivery market growth came from the regular service segment in 2019. This is due to the increasing number of partnerships between apparel retailers and logistics players in the US.

  • B2C was the largest market for same-day delivery in 2019, and the segment will offer several growth opportunities to market vendors during the forecast period. This is attributed to the growth of the online grocery market in the US.

  • The global same-day delivery market is concentrated. A1-SameDay Delivery Service Inc., Deliv, Deutsche Post AG, Express Courier, FedEx Corp., Last Mile Logistics, Power Link Expedite, United Parcel Service of America Inc., USA Couriers, and Zipline are some of the major market participants. To help clients improve their market position, this same-day delivery market forecast report provides a detailed analysis of the market leaders.

  • As the business impact of COVID-19 spreads, the global same-day delivery market 2020-2024 is expected to have positive. As the pandemic spreads in some regions and plateaus in other regions, we revaluate the impact on businesses and update our report forecasts.

Read the full report here: https://www.technavio.com/report/same-day-delivery-market-in-the-us-industry-analysis

Increasing demand from the medical and healthcare industry will be a key market trend

The US is home to many global players in the pharmaceutical industry. In 2019, the pharmaceutical industry was valued between 40% to 46% of the global value. In addition, the government spending on R&D of new drugs has been on the rise since 2014. Many pharmaceutical retailers in the country have started selling products

Global Brain Health Supplements Market to Surpass US$ 13,492.6 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global brain health supplements market is estimated to be valued at US$ 7,038.0 million in 2020 and is expected to exhibit a CAGR of 8.5% during the forecast period (2020-2027).

Key Trends and Analysis:

Key trends in the market include rising incidence of depression, anxiety and stress levels, increasing health awareness, and product launches.

Rising incidence of Alzheimer, depression, anxiety, stress, and other mental health conditions is expected to contribute to the growth of the brain health supplements market. For instance, according to data published by Alzheimer’s Association in 2017, around 5.5 million people in the U.S. of all ages were suffering from Alzheimer’s dementia.

Moreover, key players operating in the market are focused on product launches in order to expand their offerings. For instance, in June 2020, Elysium Health, in partnership with University of Oxford, U.K., announced the launch of Matter – a brain health supplement which is based on the Oxford’s VITACOG study which contains vitamin B, omega 3 lysine complex and bilberry extract for cognitive health and memory loss treatment.

Market players are investing in validating efficiency of novel products in the market. Moreover, market players are committed to offering new and improved products to address the critical unmet need for brain health supplements. For instance, in May 2020, a study conducted by researchers from Central Queensland University in collaboration with the Deakin University in Australia and Nanyang Technological University in Singapore showed positive results for USANA CopaPrime, a product of USANA Health Sciences, Inc.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4205

Key Market Takeaways:

The global brain health supplements market is expected to exhibit a CAGR of 8.5% during the forecast period, owing to increasing product launches. For instance, in April 2015, Cerebral Success, a brain-health company announced the launch of SmartX, a combination of Cognizin Citicoline with other brain health supplements to enhance and improve mental energy and focus. The company has made its products available through distribution channels such as GNC stores, Amazon.com and eSupplements.com, luckyvitamin.com.

North America is expected to hold a dominant position in the global brain health supplements market during the forecast period owing to increasing health awareness, high expenditure on supplements and adoption of inorganic growth strategies by market players. For instance, in January 2015, Synergy Strips Corp announced the acquisition of FOCUSfactor a brain health supplement brand, an asset from the Factor Nutrition Labs, LLC. The FOCUSfactor is sold at retail stores such as Costco, Sam’s Club, Walmart, Walgreens, CVS and The Vitamin Shoppe.

Competitive Landscape:

Key players operating in the global brain health supplements market are AlternaScript, LLC, Accelerated Intelligence Inc., Liquid Health, Inc., HVMN Inc., Natural Factors Nutritional Products Ltd., KeyView Labs, Inc., Onnit Labs, LLC, Purelife Bioscience Co., Ltd., Quincy Bioscience, Cerebral Success, Amway, Puori, Ocean Health, and Schiff.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4205

Market Segmentation:

  • Global Brain Health Supplements Market, By Product Type:

    • Herbal Extracts

      • Ginseng

      • Ginkgo Biloba

      • Curcumin

      • Lions Mane

      • Others

    • Vitamins & Minerals

Global Antifungal Drugs Market to Surpass US$ 13,132.8 Mn by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global antifungal drugs market is estimated to be valued at US$ 11,591.0 Mn in 2020 and is expected to exhibit a CAGR of 1.8% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Antifungal Drugs Market:

The increasing incidence of invasive candidiasis and vaginal candidiasis is expected to propel the global antifungal drugs market growth. The rising prevalence of invasive candidiasis, vaginal candidiasis, and preterm births poses high economic burden on the patient-population. For instance, according to the Centers for Disease Control and Prevention (CDC), candidemia, a form of invasive candidiasis, was one of the most common bloodstream infections in the U.S., with an average incidence of around 9 per 100,000 cases between 2013 and 2017.

Moreover, according to the same source, in 2017, around 84% of the total healthcare cost and 48% of the hospitalizations for candida infections was attributable to invasive candidiasis. The average cost per hospitalization for invasive candidiasis was around US$ 64,723 to US$ 153,090.

The increasing number of preterm births is expected to boost the market growth. For instance, according to the Kolling Institute of Medical Research published its result in 2015, that shows vaginal candidiasis can increase the risk of preterm births.

Moreover, according to a survey by researchers from the University of Miyazaki in 2017, the incidence of vulvovaginal candidiasis (VC) during pregnancy is 13 to 20% globally.

Furthermore, according to the Obstetric and Gynecology Department, Italy, 2018, VC is estimated to be the second most common cause of vaginitis and is found in 40% of women with vaginal discomfort. VC can cause systemic infections in premature neonates, particularly those with low birth weight.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/237

Key Market Takeaways:

The global antifungal drugs market is expected to exhibit a CAGR of 1.8% during the forecast period (2020-2027), owing to the increasing incidence of invasive candidiasis and vaginal candidiasis.

The growth of the North America antifungal drugs market is attributed to launches of antifungal drugs in the U.S.

Competitive Landscape:

Key players operating in the global antifungal drugs market are GlaxoSmithKline Plc, Bayer AG, Abbott Laboratories, Merck & Co., Inc, Glenmark Pharmaceuticals Limited, Enzon Pharmaceuticals, Inc., Pfizer Inc., Gilead Sciences, Inc., Sanofi S.A. and Astellas Pharma, Inc.

Buy-Now this Research report @ https://www.coherentmarketinsights.com/insight/buy-now/237

 

Market Segmentation:

  • Global Antifungal Drugs Market, By Dosage Form:

    • Powders

    • Ointments

    • Drugs

    • Others

  • Global Antifungal Drugs Market, By Region:

    • North America

    • Europe

      • U.K.

      • Germany

      • Italy

      • Spain

      • France

      • Russia

      • Rest of Europe

    • Asia Pacific

      • Australia

      • India

      • China

      • Japan

      • ASEAN

      • South Korea

      • Rest of Asia Pacific

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Rest of Latin America

    • Middle East

      • GCC

      • Israel

      • Rest of Middle East

    • Africa

      • South Africa

      • Central Africa

      • North Africa

Related Market Intelligence Report:

Brain Health Supplements Market, by Product Type (Herbal Extracts {Ginseng, Ginkgo Biloba, Curcumin, Lions Mane, and Others}, Vitamins & Minerals {Vitamin B, Vitamin C &  E, and Others}, and Natural Molecules {Acetyl-L-Carnitine, Alpha GPC, Citicoline, Docosahexaenoic Acid, and Others}), by Application (Memory

Global Precision Medicine Market 2020-2030: Remodeling the One-Size-Fits-All Theory to Individually Tailored Therapy

The MarketWatch News Department was not involved in the creation of this content.

Dublin, Sep 30, 2020 (GLOBE NEWSWIRE via COMTEX) —
Dublin, Sept. 30, 2020 (GLOBE NEWSWIRE) — The “Global Precision Medicine Market: Focus on Ecosystem, Technology, Application, Country Data (21 Countries), and Competitive Landscape – Analysis and Forecast, 2020-2030” report has been added to ResearchAndMarkets.com’s offering.

Global Precision Medicine Market to Reach $278.61 Billion by 2030

Precision medicine refers to the medicine developed as per an individual’s genetic profile. It provides guidance regarding the prevention, diagnosis, and treatment of diseases. The segmentation of the population is done depending on the genome structure of the individuals and their compatibility with a specific drug molecule.

In the precision medicine market, the application of molecular biology is to study the cause of a patient’s disease at the molecular level, so that target-based therapies or individualized therapies can be applied to cure the patient’s health-related problems.

This industry is gaining traction due to the increasing awareness about healthcare among individuals, integration of smart devices such as smartphones and tablets into healthcare, and increasing collaborations and agreements of IT firms with the diagnostics and biopharmaceutical companies for the development of precision diagnostic tools.

Within the research report, the market is segmented on the basis of product type, ecosystem application, and region, which highlight value propositions and business models useful for industry leaders and stakeholders. The research also comprises country-level analysis, go-to-market strategies of leading players, future opportunities, among others, to detail the scope and provide 360-degree coverage of the domain.

Key Topics Covered:

1 Product Definition

2 Research Scope

3 Research Methodology

4 Global Precision Medicine Market Overview
4.1 Market Definition
4.2 Precision Medicine: A Frontier in the Genesis of Patient-centric Medicine
4.3 Precision Medicine: Remodeling the One-Size-Fits-All Theory to Individually Tailored Therapy
4.4 Initiatives and Programs
4.5 Precision Medicine: Enabling Technologies and Applications
4.5.1 Innovators
4.5.1.1 3D DNA Printing
4.5.1.1.1 Introduction
4.5.1.1.2 Role of 3D DNA Printing
4.5.1.2 RNA-Seq
4.5.1.2.1 Introduction
4.5.1.2.2 Role of RNA-Seq in Precision Medicine
4.5.1.2.3 Key Players
4.5.1.3 4D Molecular Imaging
4.5.1.3.1 Introduction
4.5.1.3.2 Role of 4D Molecular Imaging in Precision Medicine
4.5.1.3.3 Key Players
4.5.2 Early Adopters
4.5.2.1 CRISPR
4.5.2.1.1 Introduction
4.5.2.1.2 Role of CRISPR in Precision Medicine
4.5.2.1.3 Key Players
4.5.2.2 Blockchain
4.5.2.3 Imaging Informatics
4.5.3 Early Majority
4.5.3.1 Artificial Intelligence (AI)
4.5.3.2 Circulating Free DNA (cfDNA)
4.5.3.3 Big Data
4.5.3.4 Next-Generation Sequencing (NGS)
4.5.3.5 Health Informatics
4.5.3.6 Bioinformatics
4.5.4 Late Majority
4.5.4.1 Polymerase Chain Reactions (PCR)
4.5.4.2 Microarray
4.6 COVID-19 Impact on the Global Precision Medicine Market

5 Market Dynamics
5.1 Overview
5.2 Market Drivers
5.2.1 Advancement of Sequencing Technologies
5.2.2 Rising Prevalence of Chronic Diseases
5.2.3 Growing Demand for Preventive Care
5.2.4 Shifting the Significance in Medicine, from Reaction to Prevention
5.2.5 Reducing Adverse Drug Reactions Through Pharmacogenomics Test
5.2.6 Potential to Reduce the Overall Healthcare Cost Across the Globe
5.3 Market Restraints
5.3.1 Unified Framework for Data Integration
5.3.2 Limited Knowledge about Molecular Mechanism/ Interaction
5.3.3 Lack of Robust Reimbursement Landscape
5.3.4 Regulatory

Global Precision Medicine Market 2020 with (COVID-19) Impact Analysis, Product Type, Application, Key Manufacturers, Regions and Forecast to 2025

The MarketWatch News Department was not involved in the creation of this content.

Sep 29, 2020 (CDN Newswire via Comtex) —
A wide-ranging analysis report titled Global Precision Medicine Market 2020 by Company, Regions, Type and Application, Forecast to 2025 provides a brief overview of the market covering the scope, size, disposition, and growth of the industry. The report presents an estimate of the current market scenario and data related to the competitive landscape of the industry. It delivers five-year industry forecasts, growth rates, and an analysis of the industry key players and their market shares. The report shows information regards to several regions that have successfully established its position in the global Precision Medicine market. The geographical and competitive dynamics of this global market will help you get a comprehensive picture of the market.

An industrial chain, market measurements regarding revenue, sales, value, capacity, regional market examination, section insightful information, and the market forecast is provided. The report gives global Precision Medicine market share analysis, as well as analyzes market position, market share, and segmented revenue. Further company and financial overview, product portfolio, new project launched, recent development analysis are the parameters added with this report.

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

DOWNLOAD FREE SAMPLE REPORT:https://www.marketquest.biz/sample-request/8778

The report investigates the development, trends, and new entrants in the sector, with elaborate profiles of the leading companies operating in the market, including: Johnson & Johnson, Novartis, Illumina, IBM, Thermo Fisher Scientific, GE Healthcare, Almac Group, Laboratory Corporation of America Holdings, Roche, Abbott Laboratories, Randox Laboratories, Intel Corporation, Healthcore, Qiagen, Biomrieux Sa, Cepheid

In market segmentation by types, the report covers: Diagnostics, Therapies

In market segmentation by applications, the report covers the following uses: Oncology, Neurosciences, Immunology, Respiratory, Others

The report provides a 5-year forecast (2020-2025) assessed based on how the global Precision Medicine market is predicted to grow in major regions like: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), MENA (Saudi Arabia, UAE, Turkey and South Africa)

Industry Size & Forecast: The report offers estimations on the global Precision Medicine market industry size on the basis of value and volume are provided in this part of the report. This report offers deep insights into the prevailing and upcoming market trends. Then it has examined the high-growth segments including product type, application, and end-users, taking into account their CAGR, share, and size. Market developments and future opportunities estimated to emerge in the market industry are looked into in this study. The forecasts are provided taking into consideration product, application, and regional segments of the market.

ACCESS FULL REPORT:https://www.marketquest.biz/report/8778/global-precision-medicine-market-2020-by-company-regions-type-and-application-forecast-to-2025

A Peek At Over the Highlights of the Report:

  • The study provides a synopsis

Organoids Market: Growing Concerns about Systematic Treatment Solutions for Personalised Medicine to Drive the Market Growth

Global Organoids Market: An Overview

The global organoids Market is a fragmented landscape with several new players driving intense competition and rising investment in innovation. Recent advancements in Big Data, and technologies like 3D printing have opened up new skies of growth for innovation.

Organoids is a simplified and compact version of organs which depicts micro-anatomy realistically. These are usually made up of stem cells, tissues, or pluripotent stem cells. These can organize themselves in three-dimensions, which is key to its realistic representation of organism.

In 2013, the scientific community named the development in organoids as one of the biggest scientific achievement in recent times. This is not surprising as understanding real-movements of organs allows scientists to study various abnormal as well as healthy behaviour in cells, and test new drugs to bring forth solutions to challenges such as Alzheimer’s disease which are yet to be completely understood. Technologies like Big Data promise to a rapid progress in understanding cells, while 3D printing promises more realistic, and more diversification in materials used for research.

Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=73363

Global Organoids Market: Trends and Opportunities

A new study published in the National Institutes of Health Journal shows that La Crosse Virus or LACV can cause inflammation of the brain in children. The study also shows that at different stages of development cycle, the cells affect children differently. The study relied on the use of organoids for the understanding the primary function of brain cells in the nervous cell system. The study and rising concerns about neurons causal relationship with LACV promise new research opportunities for end-players.

Rise in chronic diseases including most forms of cancer, and new little understood major illnesses like Alzheimer’s have rung many alarm bells in the healthcare sector. Additionally, the cost of treatment for many of these diseases remains extremely high and out of reach for many patients.

The rising population of elderly, increased investment in research for chronic illnesses, and growing burden on healthcare system are expected to drive more capital towards research and innovation. Moreover, advancements in organoids replacing conventional 2D cells with a 3D model promises new growth opportunities for researchers in return. Growing concerns about systematic treatment solutions for personalised medicine will also drive new opportunities for growth in the organoids market.

Request for Analysis of COVID-19 Impact on Organoids Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=73363

Global Organoids Market: Regional Outlook

The global organoids market report covers all regions including North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. Among these, the North American region is likely to post highest revenues, thanks to increasing technological adoption of big data, and faster streamlining process by the FDA.  The new drive to innovation in the industry is a major trend in the region as old patents expire, and new opportunities due to a bigger push by the regulatory environment drives growth in the region. The global organoids market is also expected to register robust growth in Asia Pacific, as increasing private investments for

Global Medicine Automated Dispensing Cabinet Market 2020 Industry Chain structure, Market Competition, SWOT Analysis Report by 2025

The MarketWatch News Department was not involved in the creation of this content.

Sep 29, 2020 (CDN Newswire via Comtex) —
The market study titled Global Medicine Automated Dispensing Cabinet Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 is a thorough study of the current trends leading to this vertical trend in various regions. The report describes the market by its major segments involving types, applications, and the major geographic regions. The report assesses the growth rate of the market until forecast 2025, key factors driving this market with sales, revenue, and price analysis of top manufacturers. It presents details related to market share, market size, applications, statistics, and sales. The report considers that offering an in-depth analysis of leading players is very important in order to present a market study. Therefore the report focuses on major competitors operating in this market. Next, the forecast for each product type and application segment has been provided for the 2020 to 2025 time-period has been given in the report. The market is broken down by regions, vital players, types, and applications/end-users.

Competitive Tracking:

The report offers important information related to new products launched in the global Medicine Automated Dispensing Cabinet industry, regional landscaping, various approvals, and many strategies adopted in the competitive market. Other elements such as investment feasibility investigation, investment yield analysis, potential research, rival businesses’ SWOT analyses, and market trends will also be beneficial for readers of this report. Leading players along with their market share are highlighted in the report.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

DOWNLOAD FREE SAMPLE REPORT:https://www.marketquest.biz/sample-request/8296

For the competitor segment, the report includes global key players of Medicine Automated Dispensing Cabinet are included: BD, Cerner, TOSHO, Omnicell, Aesynt, Takazono, YUYAMA, Willach Group

Product type coverage (market size & forecast, a major company of product type, etc.): General Medicine Automated Dispensing Cabinet (General ADCs), Tablet ADCs, Dose ADCs, Vial ADCs

Application coverage (market size & forecast, different demand market by region, main consumer profile, etc.): Hospital, Retail pharmacies, Other

Based on segmentation, the market report is made up of an in-depth investigation of the leading regions, including: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), MENA (Saudi Arabia, UAE, Turkey and South Africa)

Some Important Deliverables of The Report:

The research comprises customer analysis, industry cost analysis, organization profiles, market analysis by application, production, revenue, and price trend analysis by type, production and consumption analysis by region, and various other market studies. Market performance is examined in terms of revenue contribution from various segments and includes a detailed analysis of key trends, drivers, restraints, and opportunities influencing revenue growth of the global Medicine Automated Dispensing Cabinet market.

ACCESS FULL REPORT:https://www.marketquest.biz/report/8296/global-medicine-automated-dispensing-cabinet-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025

The market Offers The Following Major Components:

  • An extensive study of the global Medicine Automated Dispensing Cabinet

Regenerative Medicine Market Huge Growth Opportunities and Trends to 2025

The MarketWatch News Department was not involved in the creation of this content.

Sep 29, 2020 (Market Insight Reports) —
The Regenerative Medicine Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2026. The Regenerative Medicine market report is a valuable source of data for business strategists. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). The report explores the current outlook in global and key regions from the perspective of players, countries, product types, and end industries. This Regenerative Medicine Market study provides comprehensive data that enhances the understanding, scope, and application of this report.

Top Companies in the Global Regenerative Medicine Market
DePuy Synthes, Osiris Therapeutics, Medtronic plc (NYSE: MDT), Stryker Corporation (NYSE: SYK), Acelity, Zimmer Biomet Holdings, Inc. (NYSE: ZBH), UniQure, MiMedx Group, Cellular Dynamics International, Organogenesis, Vericel Corporation, Mesoblast, Guanhao Biotech, Vcanbio, Cytori, Golden Meditech, Bellicum Pharmaceuticals, Celgene, Gamida Cell, Stemcell Technologies, among others.

According to this study, over the next five years, the Regenerative Medicine market will register a 24.3% CAGR in terms of revenue, the global market size will reach $ 19360 million by 2025, from $ 8118.3 million in 2019.

Market Overview:
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the “process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function”. It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds, and ocular diseases.

Get a Sample PDF Copy of the Latest Research on Regenerative Medicine Market 2020 Before the purchase
https://www.marketinsightsreports.com/reports/01301807201/global-regenerative-medicine-market-growth-status-and-outlook-2020-2025/inquiry?Mode=46&Source=MW

According to the estimation of the World Health Organization, there is an increasing prevalence of diabetes among adults over the age of 18 years, which has increased to 8.5% in 2014 compared to 4.5% in 1980 across the globe. As per the estimation of the Arthritis Foundation, the number of people expected to be diagnosed from arthritis will be more than 78 million, by 2040.

The 21st Century Cures Act, approved in December 2016, created room for the establishment of the Regenerative Medicine Innovation Project (RMIP). NIH (National Institute of Health) is leading the RMIP in coordination with the FDA. The 21st Century Cures Act approved $30 million in federal awards over four years (2020-2020) for the RMIP, thus accelerating the arena by aiding clinical research on mature stem cells while endorsing the uppermost morals for scientific research and patient safety.

Market Insights:
Currently, some companies in the world can provide regenerative medicine services, mainly concentrating in the USA. The main market